E. C. Schirmer, L. Florens, T. Guan, J. R. Yates, and L. Gerace, Nuclear membrane proteins with potential disease links found by subtractive proteomics, Science, vol.301, issue.5638, p.12958361, 2003.

G. S. Wilkie, N. Korfali, S. K. Swanson, P. Malik, V. Srsen et al., Several novel nuclear envelope transmembrane proteins identified in skeletal muscle have cytoskeletal associations, Mol Cell Proteomics, vol.10, issue.1, p.20876400, 2011.

N. Korfali, G. S. Wilkie, S. K. Swanson, V. Srsen, D. G. Batrakou et al., The leukocyte nuclear envelope proteome varies with cell activation and contains novel transmembrane proteins that affect genome architecture, Mol Cell Proteomics, vol.9, issue.12, p.20693407, 2010.

K. L. Wilson and J. M. Berk, The nuclear envelope at a glance, J Cell Sci, vol.123, p.20519579, 2010.

M. W. Hetzer, T. C. Walther, and I. W. Mattaj, Pushing the envelope: structure, function, and dynamics of the nuclear periphery, Annu Rev Cell Dev Biol, vol.21, p.16212499, 2005.

S. Bione, E. Maestrini, S. Rivella, M. Mancini, S. Regis et al., Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy, Nat Genet, vol.8, issue.4, p.7894480, 1994.

A. Nagano, R. Koga, M. Ogawa, Y. Kurano, J. Kawada et al., Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy, Nat Genet, vol.12, issue.3, p.8589715, 1996.

Y. K. Hayashi, X-linked form of Emery-Dreifuss muscular dystrophy, Acta Myol, vol.24, issue.2, p.16550925, 2005.

G. Bonne, D. Barletta, M. R. Varnous, S. Bé-cane, H. M. Hammouda et al., Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy, Nat Genet, vol.21, issue.3, p.10080180, 1999.

A. E. Emery, Emery-Dreifuss muscular dystrophy-a 40 year retrospective, Neuromuscul Disord, vol.10, issue.4-5, p.10838246, 2000.

M. N. Astejada, K. Goto, A. Nagano, S. Ura, S. Noguchi et al., Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan, Acta Myol, vol.26, issue.3, p.18646565, 2007.

S. Ura, Y. K. Hayashi, K. Goto, M. N. Astejada, T. Murakami et al., Limb-girdle muscular dystrophy due to emerin gene mutations, Arch Neurol, vol.64, issue.7, p.17620497, 2007.

G. Bonne, . S. Quijano-roy, and . Emery, Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies, Handb Clin Neurol, vol.113, p.23622360, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00826557

R. Ozawa, Y. K. Hayashi, M. Ogawa, R. Kurokawa, H. Matsumoto et al., Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles, Am J Pathol, vol.168, issue.3, p.16507906, 2006.

G. Melcon, S. Kozlov, D. A. Cutler, T. Sullivan, L. Hernandez et al., Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration, Hum Mol Genet, vol.15, issue.4, p.16403804, 2006.

I. Dorboz, M. Coutelier, A. T. Bertrand, J. H. Caberg, M. Elmaleh-bergès et al., Severe dystonia, cerebellar atrophy, and cardiomyopathy likely caused by a missense mutation in TOR1AIP1, Orphanet J Rare Dis, vol.9, p.25425325, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01110718

G. Kayman-kurekci, B. Talim, P. Korkusuz, N. Sayar, T. Sarioglu et al., Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene related to nuclear envelopathies, Neuromuscul Disord, vol.24, issue.7, p.24856141, 2014.

A. Senior and L. Gerace, Integral membrane proteins specific to the inner nuclear membrane and associated with the nuclear lamina, J Cell Biol, vol.107, issue.6, pp.2029-2065, 1988.

G. Bonne, E. Mercuri, A. Muchir, A. Urtizberea, H. M. Bé-cane et al., Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene, Ann Neurol, vol.48, issue.2, p.10939567, 2000.

T. Arimura, A. Helbling-leclerc, C. Massart, S. Varnous, F. Niel et al., Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies, Hum Mol Genet, vol.14, issue.1, p.15548545, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00165763

T. Sullivan, D. Escalante-alcalde, H. Bhatt, M. Anver, N. Bhat et al., Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy, J Cell Biol, vol.147, issue.5, p.10579712, 1999.

A. Muchir, P. Pavlidis, V. Decostre, A. J. Herron, T. Arimura et al., Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy, J Clin Invest, vol.117, issue.5, p.17446932, 2007.

A. Muchir, J. Shan, G. Bonne, S. E. Lehnart, and H. J. Worman, Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins, Hum Mol Genet, vol.18, issue.2, p.18927124, 2009.

J. C. Choi, W. Wu, A. Muchir, S. Iwata, S. Homma et al., Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation, J Biol Chem, vol.287, issue.48, p.23048029, 2012.

A. Muchir, W. Wu, J. C. Choi, S. Iwata, J. Morrow et al., Abnormal p38? mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation, Hum Mol Genet, vol.21, p.22773734, 2012.

T. Arimura, K. Onoue, Y. Takahashi-tanaka, T. Ishikawa, M. Kuwahara et al., Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations, Cardiovasc Res, vol.99, issue.3, p.23631840, 2013.

A. Muchir, W. Wu, F. Sera, S. Homma, and H. J. Worman, Mitogen-activated protein kinase kinase 1/2 inhibition and angiotensin II converting inhibition in mice with cardiomyopathy caused by lamin A/C gene mutation, Biochem Biophys Res Commun, vol.452, issue.4, p.25218145, 2014.

L. Dour, C. Macquart, C. Sera, F. Homma, S. Bonne et al., Decreased WNT/?-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene, Hum Mol Genet, vol.26, issue.2, p.28069793, 2017.

J. C. Choi, W. Wu, E. Phillips, R. Plevin, F. Sera et al., Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival, Hum Mol Genet, vol.27, issue.13, p.29668927, 2018.

T. Arimura, R. Sato, N. Machida, H. Bando, D. Y. Zhan et al., Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model, J Am Coll Cardiol, vol.55, issue.14, p.20359603, 2010.

W. Wu, J. Shan, G. Bonne, H. J. Worman, and A. Muchir, Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene, Biochim Biophys Acta, vol.1802, issue.7-8, p.20388542, 2010.

W. Wu, A. Muchir, J. Shan, G. Bonne, and H. J. Worman, Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation, vol.123, p.21173351, 2011.

A. Muchir, S. A. Reilly, W. Wu, S. Iwata, S. Homma et al., Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene, Cardiovasc Res, vol.93, issue.2, p.22068161, 2012.

R. Thomasson, N. Vignier, C. Peccate, N. Mougenot, P. Noirez et al., Alteration of performance in a mouse model of Emery-Dreifuss muscular dystrophy caused by A-type lamins gene mutation, Human Molecular Genetics, 2019.

L. Clements, S. Manilal, D. R. Love, and G. E. Morris, Direct interaction between emerin and lamin A, Biochem Biophys Res Commun, vol.267, issue.3, p.10673356, 2000.

M. Sakaki, H. Koike, N. Takahashi, N. Sasagawa, S. Tomioka et al., Interaction between emerin and nuclear lamins, J Biochem, vol.129, issue.2, p.11173535, 2001.

V. Andrés and J. M. González, Role of A-type lamins in signaling, transcription, and chromatin organization, J Cell Biol, vol.187, issue.7, pp.945-57, 2009.

J. M. Holaska and K. L. Wilson, An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture, Biochemistry, vol.46, issue.30, p.17620012, 2007.

R. Ben-yaou, A. Toutain, T. Arimura, L. Demay, C. Massart et al., Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism?, Neurology, vol.68, issue.22, p.17536044, 2007.

S. Brunelli, C. Sciorati, D. 'antona, G. Innocenzi, A. Covarello et al., Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy, Proc Natl Acad Sci, vol.104, issue.1, p.17182743, 2007.

R. Matsuda, A. Nishikawa, and H. Tanaka, Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle, J Biochem, vol.118, issue.5, p.8749313, 1995.

A. Muchir, Y. J. Kim, S. A. Reilly, W. Wu, J. C. Choi et al., Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation, Skelet Muscle, vol.3, issue.1, p.23815988, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00842001

E. Wada, J. Tanihata, A. Iwamura, S. Takeda, Y. K. Hayashi et al., Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/ utrophin-deficient mice, Skelet Muscle, vol.7, issue.1, p.29078808, 2017.

M. Chatzifrangkeskou, L. Dour, C. Wu, W. Morrow, J. P. Joseph et al., ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene, Hum Mol Genet, vol.25, issue.11, p.27131347, 2016.

V. Nikolova, C. Leimena, A. C. Mcmahon, J. C. Tan, S. Chandar et al., Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice, J Clin Invest, vol.113, issue.3, p.14755333, 2004.

H. B. Steele-stallard, L. Pinton, S. Sarcar, T. Ozdemir, S. M. Maffioletti et al., Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic. Front Physiol, vol.9, p.30405424, 2018.

Y. E. Park, Y. K. Hayashi, K. Goto, H. Komaki, Y. Hayashi et al., Nuclear changes in skeletal muscle extend to satellite cells in autosomal dominant Emery-Dreifuss muscular dystrophy/limb-girdle muscular dystrophy 1B, Neuromuscul Disord, vol.19, issue.1, p.19070492, 2009.

Y. E. Park, Y. K. Hayashi, G. Bonne, T. Arimura, S. Noguchi et al., Autophagic degradation of nuclear components in mammalian cells, Autophagy, vol.5, issue.6, p.19550147, 2009.

H. J. Worman and G. Bonne, Laminopathies": a wide spectrum of human diseases, Exp Cell Res, vol.313, issue.10, p.17467691, 2007.

B. Burke and C. L. Stewart, The laminopathies: the functional architecture of the nucleus and its contribution to disease, Annu Rev Genomics Hum Genet, vol.7, p.16824021, 2006.

L. Maggi, N. Carboni, and P. Bernasconi, Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features, Cells, vol.5, issue.3, 2016.

A. Janin, D. Bauer, F. Ratti, and G. Millat, Mé jat A. Nuclear envelopathies: a complex LINC between nuclear envelope and pathology, Orphanet J Rare Dis, vol.12, issue.1, p.28854936, 2017.

C. Y. Ho, D. E. Jaalouk, and J. Lammerding, Novel insights into the disease etiology of laminopathies, Rare Dis, vol.1, issue.1, p.24860693, 2013.